NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001170

Registered date:01/05/2014

Treatment efficacy of short-term PEG-IFN alpha for chronic hepatitis C patients with genotype 2 and low viral road

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedchronic hepatitis C
Date of first enrollment2008/05/01
Target sample size220
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)a group of short-term PEG-IFN alpha therapy a group of ordinary-term PEG-IFN alpha therapy

Outcome(s)

Primary OutcomeHCV-RNA
Secondary Outcometransaminase

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criterialiver dysfunction with other causes Allergy to Interferon (IFN) during pregnancy Severe comlication-especially, poor hematopoiesis, renal, cardiac or respiratory function

Related Information

Contact

public contact
Name Ken Sato
Address 3-39-15 Showa, Maebashi, Gunma, 371-8511, Japan Japan
Telephone 027-220-8127
E-mail satoken@gunma-u.ac.jp
Affiliation Gunma University Graduate School of Medicine Department of Medicine and Molecular Science
scientific contact
Name Ken Sato
Address 3-39-15 Showa, Maebashi, Gunma, 371-8511, Japan Japan
Telephone 027-220-8127
E-mail satoken@gunma-u.ac.jp
Affiliation Gunma University Graduate School of Medicine Department of Medicine and Molecular Science